Clinical Trials Directory

Trials / Completed

CompletedNCT07523451

COMPARISON BETWEEN DIFFERENT CONCENTRATIONS OF OZONE GAS AS AN INTRA-ARTICULAR INJECTION FOR TREATMENT OF INTERNAL DERANGEMENT OF TEMPROMANDIBULAR JOINT

COMPARISON BETWEEN DIFFERENT CONCENTRATIONS OF OZONE GAS AS AN INTRA-ARTICULAR INJECTION FOR TREATMENT OF INTERNAL DERANGEMENT OF TEMPROMANDIBULAR JOINT (A RANDOMIZED CONTROLLED CLINICAL TRIAL)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Alexandria University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The intra-articular injection is considered the first line of minimally invasive treatment of joint disease as it has an analgesic, antimicrobial effect and an immune system stimulating action as it is one of the most powerful detoxication agents.

Detailed description

Aim of the study: This study aims to evaluate the therapeutic effect of intra-articular injection of two different concentrations of ozone gas in the treatment of internal derangement of TMJ. A total of 20 patients suffering from internal derangement of TMJ will be included in the study. These patients will be randomly assigned to one of two groups. Group A will receive 2 ml ozone-oxygen gas mixture that will be injected intra-articularly with concentration 5 microns/ml (study group). Group B will receive 2ml intra articular ozone-oxygen gas injection with concentration 10 microns/ml (control group). Both groups will receive three sessions of intraarticular injection, one session per week. The first session will be arthrocentesis by ozonated water as a lavage then intraarticular injection with ozone-oxygen gas mixture. Then, the other two sessions will be intraarticular gas injection only. Assessment will be done by measuring the maximum mouth opening and by using Helkimo's index to measure the improvement of symptoms .The follow up period will be 1 month , 3 months and 6 months after the sessions.

Conditions

Interventions

TypeNameDescription
OTHERPatients will be treated with 2ml ozone oxygen mixture with concentration 5 micron/mlPatients will be treated with 2ml ozone oxygen mixture with concentration 5 micron/ml
OTHERPatients will be treated with 2ml ozone oxygen mixture with concentration 10 micron/mlPatients will be treated with 2ml ozone oxygen mixture with concentration 10 micron/ml

Timeline

Start date
2025-02-01
Primary completion
2025-10-30
Completion
2026-04-01
First posted
2026-04-13
Last updated
2026-04-13

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07523451. Inclusion in this directory is not an endorsement.